Natural Capsules Limited (NATCAPSUQ) — Financial Results | 13 August 2026(2 announcements)

Natural Capsules Limited reported consolidated revenue of ₹48.71 crores for Q1FY27, down 17% QoQ but up 8% YoY, with EBITDA at ₹1.12 crores reflecting a 251% YoY surge. PAT stood at ₹5.74 crores, up 3% YoY. The company highlighted margin resilience amid input cost pressures, rupee depreciation tailwinds, and operational disruptions from ERP migration. It also detailed strategic shifts in its HPMC and API segments, including capacity conversions and new contract wins. Forward-looking statements emphasize confidence in sustained capsule profitability and API scale-up, supported by regulatory progress and PLI incentives.

Natural Capsules Limited reported Q1FY27 results showing revenue of [amount not verified] and EBITDA of ₹1.12 crores with EBITDA margin of 2.30%. PAT was ₹5.74 crores reflecting a 15% YoY increase. The company highlighted margin resilience from input cost pass-throughs, gelatine capsule profitability, and rupee depreciation benefits. It noted temporary HPMC line conversion to gelatine to protect margins amid US market uncertainty and geopolitical headwinds in API exports. Despite disruptions from ERP implementation affecting final quarter sales, management expressed confidence in sustained capsule performance and API progress including new contracts and backward integration milestones.